Impact of pharmacist intervention in reducing vancomycin-associated acute kidney injury: A systematic review and meta-analysis.
Kun-Ming PanJiang XiaotianXu QingChenqi XuDing XiaoqiangLv Qian ZhouPublished in: British journal of clinical pharmacology (2022)
Pharmacist intervention in vancomycin treatment significantly decreased the rate of vancomycin-associated AKI, while improving efficacy and reducing mortality. We speculate that this is because the pharmacist interventions optimized the rationality of vancomycin therapy, monitoring of vancomycin trough concentration and the monitoring of patients' renal function.
Keyphrases
- methicillin resistant staphylococcus aureus
- acute kidney injury
- randomized controlled trial
- end stage renal disease
- ejection fraction
- newly diagnosed
- cardiac surgery
- chronic kidney disease
- staphylococcus aureus
- prognostic factors
- type diabetes
- stem cells
- cardiovascular disease
- risk factors
- patient reported outcomes
- cell therapy